PMID- 31489272 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 11 IP - 8 DP - 2019 Aug 21 TI - Sudden-onset Hypoglycemia Following Fluid Replacement in a Patient with Dapagliflozin-induced Diabetic Ketoacidosis Without Prior Insulin Use: Case Report. PG - e5448 LID - 10.7759/cureus.5448 [doi] LID - e5448 AB - Euglycemic diabetic ketoacidosis (DKA) is a known complication of sodium-glucose co-transporter 2 (SGLT-2) inhibitors that have been reported in the literature. The prevalence of this side effect is growing and the exact mechanism of action on why this happens is unknown. Hypoglycemia events are very rare in diabetic patients using SGLT-2 inhibitors and/or metformin when they have normal kidney function. We report a novel complication of hypoglycemia that occurred during the course of treatment of SGLT2 inhibitor-induced DKA in a patient with type 2 diabetes mellitus (T2DM) on the dapagliflozin-metformin combination. FAU - Elshimy, Ghada AU - Elshimy G AD - Endocrinology, Diabetes and Metabolism, University of Arizona College of Medicine-Phoenix, Phoenix, USA. FAU - Correa, Ricardo AU - Correa R AD - Endocrinology, Diabetes and Metabolism, University of Arizona College of Medicine-Phoenix, Phoenix, USA. LA - eng PT - Case Reports DEP - 20190821 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC6713257 OTO - NOTNLM OT - diabetic ketoacidosis OT - hypoglycemia OT - metformin OT - sodium-glucose co transporter-2 (sglt2) inhibitors COIS- The authors have declared that no competing interests exist. EDAT- 2019/09/07 06:00 MHDA- 2019/09/07 06:01 PMCR- 2019/08/21 CRDT- 2019/09/07 06:00 PHST- 2019/09/07 06:00 [entrez] PHST- 2019/09/07 06:00 [pubmed] PHST- 2019/09/07 06:01 [medline] PHST- 2019/08/21 00:00 [pmc-release] AID - 10.7759/cureus.5448 [doi] PST - epublish SO - Cureus. 2019 Aug 21;11(8):e5448. doi: 10.7759/cureus.5448.